185 related articles for article (PubMed ID: 27521313)
21. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
Kim YR; Kim JS; Cheong JW; Song JW; Min YH
Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
[TBL] [Abstract][Full Text] [Related]
22. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.
Majhail NS; DeFor T; Lazarus HM; Burns LJ
Biol Blood Marrow Transplant; 2008 Jul; 14(7):790-4. PubMed ID: 18541198
[TBL] [Abstract][Full Text] [Related]
23. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
[TBL] [Abstract][Full Text] [Related]
24. Does ferritin level affect the outcomes of autologous stem cell transplantation equally in all diseases?
Uysal A; Erkurt MA; Kuku İ; Kaya E; Sarıcı A; Berber İ; Biçim S; Hidayet E; Kaya A; Arslan S; Cırık S
Transfus Apher Sci; 2023 Jun; 62(3):103655. PubMed ID: 36805278
[TBL] [Abstract][Full Text] [Related]
25. Does iron overload really matter in stem cell transplantation?
Armand P; Sainvil MM; Kim HT; Rhodes J; Cutler C; Ho VT; Koreth J; Alyea EP; Neufeld EJ; Kwong RY; Soiffer RJ; Antin JH
Am J Hematol; 2012 Jun; 87(6):569-72. PubMed ID: 22473510
[TBL] [Abstract][Full Text] [Related]
26. Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation.
Chotsampancharoen T; Gan K; Kasow KA; Barfield RC; Hale GA; Leung W
Pediatr Transplant; 2009 May; 13(3):348-52. PubMed ID: 18518909
[TBL] [Abstract][Full Text] [Related]
27. Management of high ferritin in long-term survivors after hematopoietic stem cell transplantation.
Brissot E; Savani BN; Mohty M
Semin Hematol; 2012 Jan; 49(1):35-42. PubMed ID: 22221783
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy.
Tanaka M; Kanamori H; Matsumoto K; Tachibana T; Numata A; Ohashi K; Kobayashi T; Nakaseko C; Kanda Y; Yamazaki E; Fujisawa S; Ooi J; Sakura T; Aotsuka N; Onoda M; Machida S; Kato J; Usuki K; Watanabe R; Taguchi J; Yano S; Saito T; Takahashi S; Sakamaki H; Okamoto S;
Bone Marrow Transplant; 2015 May; 50(5):727-33. PubMed ID: 25730191
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload.
Ozyilmaz E; Aydogdu M; Sucak G; Aki SZ; Ozkurt ZN; Yegin ZA; Kokturk N
Bone Marrow Transplant; 2010 Oct; 45(10):1528-33. PubMed ID: 20118991
[TBL] [Abstract][Full Text] [Related]
30. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation.
Altès A; Remacha AF; Sureda A; Martino R; Briones J; Canals C; Brunet S; Sierra J; Gimferrer E
Bone Marrow Transplant; 2002 Jun; 29(12):987-9. PubMed ID: 12098067
[TBL] [Abstract][Full Text] [Related]
31. The oral iron chelator deferasirox might improve survival in allogeneic hematopoietic cell transplant (alloHSCT) recipients with transfusional iron overload.
Sivgin S; Baldane S; Akyol G; Keklik M; Kaynar L; Kurnaz F; Pala C; Zararsiz G; Cetin M; Eser B; Unal A
Transfus Apher Sci; 2013 Oct; 49(2):295-301. PubMed ID: 23916904
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.
Meyer SC; O'Meara A; Buser AS; Tichelli A; Passweg JR; Stern M
Biol Blood Marrow Transplant; 2013 Mar; 19(3):440-4. PubMed ID: 23089566
[TBL] [Abstract][Full Text] [Related]
33. Pro-oxidative/antioxidative imbalance: a key indicator of adverse outcome in hematopoietic stem cell transplantation.
Yegin ZA; Paşaoğlu H; Aki SZ; Özkurt ZN; Demirtaş C; Yağci M; Acar K; Sucak GT
Int J Lab Hematol; 2011 Aug; 33(4):414-23. PubMed ID: 21310008
[TBL] [Abstract][Full Text] [Related]
34. Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children.
Lee JW; Kang HJ; Kim EK; Kim H; Shin HY; Ahn HS
Bone Marrow Transplant; 2009 Dec; 44(12):793-7. PubMed ID: 19398966
[TBL] [Abstract][Full Text] [Related]
35. Iron overload in allogeneic hematopoietic stem cell transplant recipients.
Ali S; Pimentel JD; Munoz J; Shah V; McKinnon R; Divine G; Janakiraman N
Arch Pathol Lab Med; 2012 May; 136(5):532-8. PubMed ID: 22540302
[TBL] [Abstract][Full Text] [Related]
36. Impact of prohepcidin levels and iron parameters on early post-transplantation toxicities.
Akı SZ; Paşaoğlu H; Yeğin ZA; Suyanı E; Demirtaş CY; Ozkurt ZN; Yağcı M; Sucak GT
Hematology; 2011 Sep; 16(5):284-90. PubMed ID: 21902892
[TBL] [Abstract][Full Text] [Related]
37. Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT).
Hilken A; Langebrake C; Wolschke C; Kersten JF; Rohde H; Nielsen P; Kröger N
Ann Hematol; 2017 Aug; 96(8):1379-1388. PubMed ID: 28585071
[TBL] [Abstract][Full Text] [Related]
38. Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.
Goto T; Ikuta K; Inamoto Y; Kamoshita S; Yokohata E; Koyama D; Onodera K; Seto A; Watanabe K; Imahashi N; Tsukamoto S; Ozawa Y; Sasaki K; Ito M; Kohgo Y; Miyamura K
Int J Hematol; 2013 Jan; 97(1):125-34. PubMed ID: 23264147
[TBL] [Abstract][Full Text] [Related]
39. Is there any relationship between pulmonary function tests and post-transplant complications of allogeneic hematopoetic stem cell transplantation?
Aydoğdu M; Ozyilmaz E; Köktürk N; Yeğin ZA; Özkurt ZN; Aki ZS; Sucak G
Minerva Med; 2012 Jun; 103(3):189-98. PubMed ID: 22653099
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of elevated pretreatment serum ferritin in patients with high-risk MDS treated with azacitidine.
Laribi K; Bolle D; Alani M; Ghnaya H; Le Bourdelles S; Besançon A; Farhi J; Denizon N; Baugier de Materre A
Exp Hematol; 2018 Sep; 65():34-37. PubMed ID: 29883686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
